Clinical Trial Update: Fluoxetine for Motor Recovery After Acute Intracerebral Hemorrhage [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fluoxetine for motor recovery after acute intracerebral hemorrhage has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage
• Motor Impairment

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Universidad Autónoma de Aguascalientes | Conditions: Intracerebral Hemorrhage, Motor Impairment | Phase 3 | Status: TERMINATED